Complete Response Letter Issued for Keratoconus and Corneal Ectasia NDA Monthly Prescribing Reference Patients with these sight-threatening conditions may require corneal transplant surgery. RELATED: Ophthalmic Disorders Resource Center. If approved, the riboflavin ophthalmic solution/KXL System would be the first FDA approved therapeutic treatment for ... Avedro Announces Receipt of Complete Response Letter from FDA for Corneal ... |
